Skip to content
healthcare.dev
Get a free key

Litfulo

NDC 63539-334, ritlecitinib, capsule, from U.S. Pharmaceuticals.

Product NDC
63539-334
Status
Listed
Labeler
U.S. Pharmaceuticals
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA215830
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63539-334 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RITLECITINIB TOSYLATE50 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Janus Kinase 3 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Tyrosine Kinase Inhibitors [MoA]

Package NDCNDC-11Package
63539-334-286353903342828 CAPSULE in 1 BOTTLE (63539-334-28)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1882f799-61b0-4813-965a-4910c4ae419c

Use it

Look up 63539-334 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63539-334 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63539-334. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.